Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1990 2
1991 1
1993 1
1994 1
1996 1
1998 1
1999 5
2000 1
2002 1
2003 1
2004 2
2006 1
2007 2
2008 4
2009 2
2010 1
2011 2
2012 2
2013 1
2014 1
2015 1
2016 2
2017 3
2018 3
2019 2
2020 3
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

45 results
Results by year

Citations

2 articles found by citation matching

Search results

Filters applied: . Clear all
Page 1
Patients with type 1 diabetes mellitus have impaired IL-1β production in response to Mycobacterium tuberculosis.
Lachmandas E, Thiem K, van den Heuvel C, Hijmans A, de Galan BE, Tack CJ, Netea MG, van Crevel R, van Diepen JA. Lachmandas E, et al. Eur J Clin Microbiol Infect Dis. 2018 Feb;37(2):371-380. doi: 10.1007/s10096-017-3145-y. Epub 2017 Nov 30. Eur J Clin Microbiol Infect Dis. 2018. PMID: 29189980 Free PMC article.
Patients with diabetes mellitus have an increased risk of developing tuberculosis. Although the underlying mechanism is unclear, evidence suggests a role for chronic hyperglycaemia. We examined the influence of hyperglycaemia on Mycobacterium tuberc
Patients with diabetes mellitus have an increased risk of developing tuberculosis. Although the underlying mechanism is …
BCG turns 100: its nontraditional uses against viruses, cancer, and immunologic diseases.
Singh AK, Netea MG, Bishai WR. Singh AK, et al. J Clin Invest. 2021 Jun 1;131(11):e148291. doi: 10.1172/JCI148291. J Clin Invest. 2021. PMID: 34060492 Free PMC article. Review.
First administered to a human subject as a tuberculosis (TB) vaccine on July 18, 1921, Bacillus Calmette-Guerin (BCG) has a long history of use for the prevention of TB and later the immunotherapy of bladder cancer. ...While its roles for TB prevention and bladder cancer i …
First administered to a human subject as a tuberculosis (TB) vaccine on July 18, 1921, Bacillus Calmette-Guerin (BCG) has a long hist …
Prevalence of pulmonary tuberculosis in young adult patients with Type 1 diabetes mellitus in India.
Nair A, Guleria R, Kandasamy D, Sharma R, Tandon N, Singh UB, Goswami R. Nair A, et al. Multidiscip Respir Med. 2016 May 10;11:22. doi: 10.1186/s40248-016-0058-z. eCollection 2016. Multidiscip Respir Med. 2016. PMID: 27168934 Free PMC article.
BACKGROUND: There is limited information on prevalence of pulmonary tuberculosis (PTB) in patients with type-1-diabetes. We assessed the prevalence of PTB in patients with type-1-diabetes attending the outpatient-clinic in a tertia …
BACKGROUND: There is limited information on prevalence of pulmonary tuberculosis (PTB) in patients with type-1-diabe
Higher susceptibility of type 1 diabetic rats to Mycobacterium tuberculosis infection.
Sugawara I, Mizuno S. Sugawara I, et al. Tohoku J Exp Med. 2008 Dec;216(4):363-70. doi: 10.1620/tjem.216.363. Tohoku J Exp Med. 2008. PMID: 19060451 Free article.
An association between diabetes mellitus and tuberculosis has been implicated for a long time. ...Here, we used the Komeda diabetes-prone (KDP) rat, as a model of type 1 diabetes mellitus. The infected KDP rats developed lar …
An association between diabetes mellitus and tuberculosis has been implicated for a long time. ...Here, we used the Kom …
Understanding the increased risk of infections in diabetes: innate and adaptive immune responses in type 1 diabetes.
Janssen AWM, Stienstra R, Jaeger M, van Gool AJ, Joosten LAB, Netea MG, Riksen NP, Tack CJ. Janssen AWM, et al. Metabolism. 2021 Aug;121:154795. doi: 10.1016/j.metabol.2021.154795. Epub 2021 May 8. Metabolism. 2021. PMID: 33971203
AIMS: Patients with diabetes have a higher incidence of infections with Candida albicans, Staphylococcus aureus and Mycobacterium tuberculosis, yet factors contributing to this increased risk are largely unknown. ...In response to stimulation with M. tuber
AIMS: Patients with diabetes have a higher incidence of infections with Candida albicans, Staphylococcus aureus and Mycobacterium
High prevalence of Mycobacterium tuberculosis infection and disease in children and adolescents with type 1 diabetes mellitus.
Webb EA, Hesseling AC, Schaaf HS, Gie RP, Lombard CJ, Spitaels A, Delport S, Marais BJ, Donald K, Hindmarsh P, Beyers N. Webb EA, et al. Int J Tuberc Lung Dis. 2009 Jul;13(7):868-74. Int J Tuberc Lung Dis. 2009. PMID: 19555537
SETTING: Western Cape Province, South Africa. OBJECTIVES: To describe the prevalence of tuberculosis (TB) infection and disease in children with type 1 diabetes and to investigate the association between glycaemic control and prevalence of TB infection …
SETTING: Western Cape Province, South Africa. OBJECTIVES: To describe the prevalence of tuberculosis (TB) infection and disease in ch …
Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype.
Toubiana J, Okada S, Hiller J, Oleastro M, Lagos Gomez M, Aldave Becerra JC, Ouachée-Chardin M, Fouyssac F, Girisha KM, Etzioni A, Van Montfrans J, Camcioglu Y, Kerns LA, Belohradsky B, Blanche S, Bousfiha A, Rodriguez-Gallego C, Meyts I, Kisand K, Reichenbach J, Renner ED, Rosenzweig S, Grimbacher B, van de Veerdonk FL, Traidl-Hoffmann C, Picard C, Marodi L, Morio T, Kobayashi M, Lilic D, Milner JD, Holland S, Casanova JL, Puel A; International STAT1 Gain-of-Function Study Group. Toubiana J, et al. Blood. 2016 Jun 23;127(25):3154-64. doi: 10.1182/blood-2015-11-679902. Epub 2016 Apr 25. Blood. 2016. PMID: 27114460 Free PMC article.
Invasive fungal infections (10%), mostly caused by Candida spp. (29%), and mycobacterial disease (6%) caused by Mycobacterium tuberculosis, environmental mycobacteria, or Bacille Calmette-Guerin vaccines were less common. Many patients had autoimmune manifestations …
Invasive fungal infections (10%), mostly caused by Candida spp. (29%), and mycobacterial disease (6%) caused by Mycobacterium tube
TNF, TNF inducers, and TNFR2 agonists: A new path to type 1 diabetes treatment.
Faustman DL. Faustman DL. Diabetes Metab Res Rev. 2018 Jan;34(1). doi: 10.1002/dmrr.2941. Epub 2017 Sep 29. Diabetes Metab Res Rev. 2018. PMID: 28843039 Review.
In the past decade, interest in the century-old tuberculosis vaccine, bacillus Calmette-Guerin (BCG), has been revived for potential new therapeutic uses in type 1 diabetes and other forms of autoimmunity. ...In human clinical trials in both type
In the past decade, interest in the century-old tuberculosis vaccine, bacillus Calmette-Guerin (BCG), has been revived for potential …
Impact of diabetes on the natural history of tuberculosis.
Restrepo BI, Schlesinger LS. Restrepo BI, et al. Diabetes Res Clin Pract. 2014 Nov;106(2):191-9. doi: 10.1016/j.diabres.2014.06.011. Epub 2014 Jul 14. Diabetes Res Clin Pract. 2014. PMID: 25082309 Free PMC article. Review.
Tuberculosis (TB) is the number one bacterial killer worldwide and the current increase in type 2 diabetes mellitus patients (DM), particularly in countries where TB is also endemic, has led to the re-emerging importance of DM2 as a risk factor for TB.
Tuberculosis (TB) is the number one bacterial killer worldwide and the current increase in type 2 diabetes mellitus
Associations between Diabetes Mellitus and Nontuberculous Mycobacterium-Caused Diseases in Taiwan: A Nationwide Cohort Study.
Wang JY, Lin HC, Lin HA, Chung CH, Chen LC, Huang KY, Sun CA, Chien WC, Guo JL. Wang JY, et al. Am J Trop Med Hyg. 2021 Oct 18;105(6):1672-1679. doi: 10.4269/ajtmh.20-1441. Am J Trop Med Hyg. 2021. PMID: 34662865
Patients with diabetes mellitus (DM) are at greater risk of developing active tuberculosis and other intracellular bacterial infections, although the risk of acquiring infections from nontuberculous Mycobacterium (NTM) remains undefined. ...In conclusi …
Patients with diabetes mellitus (DM) are at greater risk of developing active tuberculosis and other intracellular bact …
45 results